Architects of pathways without precedent.
A collective of regulatory thinkers who have been there, done that, and know where decisive evidence lives.
The best and brightest, assembled around the problem.
We are a collective of thought leaders who have been there and done that. We find the ‘it’ that supports an innovative regulatory pathway. Direct access to key opinion leaders, regulators and executives enables us to deliver successful outcomes. We are passionate about rare diseases and curious about novel science.
Rapidly evolving medical product regulations and regulatory conservatism create a complex environment for developing and commercializing new therapeutics and treatment modalities. We have helped startups launch first approved products and supported globally recognized brands throughout the product lifecycle.
Unconventional, collaborative and built to move.
Our experienced global team works wherever the problem requires—from home offices and co-working spaces to farms, rainforests, beaches, trains, planes and mountains. We support the ongoing health and wellness of our employees and their families while working together to provide breakthrough solutions to regulatory challenges.
4,000+
Health Authority Meetings
2,000+
Therapeutic Programs
100+
Countries
Why it matters“Regulatory science and medical product development can fight disease.”
We believe regulatory science and medical product development can fight disease and improve health outcomes. The balance between innovation, regulation and stakeholders in medical product approvals is delicate.
From rescuing programs after devastating clinical trial results or unfavorable health authority outcomes to optimizing development and shortening review timelines, we save clients time and money—which translates into years of patient quality of life.
Experience belongs at the decisive moment.
Share the regulatory decision, development challenge or pathway that needs experienced judgment.
Schedule a consultation